Zelira Lands In Germany With Distribution Agreement For Cannabinoid Sleep Medication

Australia-based Zelira Therapeutics Ltd. (OTCQB: ZLDAF), a company developing cannabinoid-based medicines, announced that it is entering the German market via a 5-year exclusive distribution agreement with IM Corp. (CSE: IMCC) (NASDAQ: IMCC).

Distribution will be done by IM ’ subsidiary, German-based Adjupharm, a …

Full story available on Benzinga.com

More Zelira Lands In Germany With Distribution Agreement For Cannabinoid Sleep Medication